U.S. Markets closed

Veracyte: 2Q Earnings Snapshot

SOUTH SAN FRANCISCO, Calif. (AP) _ Veracyte Inc. (VCYT) on Tuesday reported a loss of $2.5 million in its second quarter.

On a per-share basis, the South San Francisco, California-based company said it had a loss of 5 cents.

The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 9 cents per share.

The molecular diagnostic company posted revenue of $30.1 million in the period, also beating Street forecasts. Three analysts surveyed by Zacks expected $29.2 million.

Veracyte expects full-year revenue in the range of $119 million to $122 million.

Veracyte shares have more than doubled since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $29.61, more than doubling in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VCYT at https://www.zacks.com/ap/VCYT